These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 18503613)

  • 1. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
    Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
    Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.
    Lin L; Conlan MG; Tessman J; Cimino G; Porter S
    Transfusion; 2005 Oct; 45(10):1610-20. PubMed ID: 16181212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.
    Jauvin V; Alfonso RD; Guillemain B; Dupuis K; Fleury HJ
    Transfusion; 2005 Jul; 45(7):1151-9. PubMed ID: 15987361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets.
    Castro E; Gironés N; Bueno JL; Carrión J; Lin L; Fresno M
    Transfusion; 2007 Mar; 47(3):434-41. PubMed ID: 17319823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.
    Lin L; Dikeman R; Molini B; Lukehart SA; Lane R; Dupuis K; Metzel P; Corash L
    Transfusion; 2004 Oct; 44(10):1496-504. PubMed ID: 15383024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.
    Tonnetti L; Proctor MC; Reddy HL; Goodrich RP; Leiby DA
    Transfusion; 2010 May; 50(5):1019-27. PubMed ID: 20030791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.
    Pineda A; McCullough J; Benjamin RJ; Cable R; Strauss RG; Burgstaler E; Porter S; Lin L; Metzel P; Conlan MG;
    Transfusion; 2006 Apr; 46(4):562-71. PubMed ID: 16584432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
    Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A
    Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats.
    Ciaravino V; Hanover J; Lin L; Sullivan T; Corash L
    Transfusion; 2009 May; 49(5):985-94. PubMed ID: 19175545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiation.
    Eastman RT; Barrett LK; Dupuis K; Buckner FS; Van Voorhis WC
    Transfusion; 2005 Sep; 45(9):1459-63. PubMed ID: 16131378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of Babesia microti in red blood cells and platelet concentrates.
    Tonnetti L; Laughhunn A; Thorp AM; Vasilyeva I; Dupuis K; Stassinopoulos A; Stramer SL
    Transfusion; 2017 Oct; 57(10):2404-2412. PubMed ID: 28872685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
    Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
    Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers.
    Schlenke P; Hervig T; Isola H; Wiesel ML; Kientz D; Pinkoski L; Singh Y; Lin L; Corash L; Cazenave JP
    Transfusion; 2008 Apr; 48(4):697-705. PubMed ID: 18194378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates.
    Bruchmüller I; Janetzko K; Bugert P; Mayaudon V; Corash L; Lin L; Klüter H
    Transfusion; 2005 Sep; 45(9):1464-72. PubMed ID: 16131379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
    Snyder E; McCullough J; Slichter SJ; Strauss RG; Lopez-Plaza I; Lin JS; Corash L; Conlan MG;
    Transfusion; 2005 Dec; 45(12):1864-75. PubMed ID: 16371039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Keil SD; Kiser P; Sullivan JJ; Kong AS; Reddy HL; Avery A; Goodrich RP
    Transfusion; 2013 Oct; 53(10):2278-86. PubMed ID: 23320495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.
    Tonnetti L; Thorp AM; Reddy HL; Keil SD; Goodrich RP; Leiby DA
    Transfusion; 2013 Apr; 53(4):860-7. PubMed ID: 22803831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections.
    Roback JD; Conlan M; Drew WL; Ljungman P; Nichols WG; Preiksaitis JK
    Transfus Med Rev; 2006 Jan; 20(1):45-56. PubMed ID: 16373187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.